Primary information |
---|
ID | 1223 |
Peptide Name | sequence no 4 |
Sequence | HFKRPLPPLPSL |
Length | 12 |
Chirality | L |
N-terminal Modification | None |
C-terminal Modification | None |
Chemical Modification | None |
Linear/ Cyclic | Linear |
Nature | Synthetic |
Source of Origin | NA |
Target | T-cell, Hematopoietic cell |
Mechanism of Action | Human T-cell tyrosine kinase (Lck) inhibitor, Hematopoietic cell kinase (Hck) inhibitor |
In vitro/In vivo | In vitro |
Cell Line | NA |
Inhibition Concentartion | NA |
In vivo Model | NA |
Assay | Lck-SH3 binding assay, NMR Spectroscopy, protein-protein interactions assay by PepSpot membranes |
Lethal Dose | NA |
Combination Therapy | NA |
Pubmed ID | EP 1983050 A1 |
Year of Publication | 2008 |
3-D Structure | View in Jmol or Download Structure |